Stocks and Investing Stocks and Investing
Fri, September 8, 2023

Joseph Schwartz Upgraded (SPRB) to Buy and Increased Target to $9 on, Sep 8th, 2023


Published on 2024-10-28 06:19:35 - WOPRAI, Joseph Schwartz
  Print publication without navigation


Joseph Schwartz of SVB Leerink, Upgraded "Spruce Biosciences, Inc." (SPRB) to Buy and Increased Target from $3 to $9 on, Sep 8th, 2023.

Joseph has made no other calls on SPRB in the last 4 months.



There are 5 other peers that have a rating on SPRB. Out of the 5 peers that are also analyzing SPRB, 0 agree with Joseph's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Joseph


  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Decreased Target to $7 on, Friday, August 18th, 2023
  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $10 on, Friday, August 18th, 2023
  • Jonathan Wolleben of "JMP Securities" Maintained at Buy with Increased Target to $8 on, Wednesday, August 16th, 2023
  • Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $8 on, Tuesday, August 15th, 2023
  • Tiago Fauth of "Credit Suisse" Reiterated at Buy and Held Target at $4 on, Tuesday, May 16th, 2023

Contributing Sources